That we observe association of higher PCSK9 with fewer ICU and ventilator free days but not mortality is consistent with prior literature that the association between circulating PCSK9 levels and clinical outcomes are at best mixed and unclear, perhaps due to the heterogenous causes of death in ARDS (27). This evidence concerns the gene PCSK9 and acute respiratory distress syndrome.